Characteristic | Value |
---|---|
Sex: Male/Female, n | 6/11 |
Mean age, years (range) | 37.2 (20-53) |
Median time since asthma diagnosis, years (range) | 20.2 (3-42) |
Mean inhaled corticosteroid dose prior to the study, μg (range) | 553 (200-800) |
User of long-acting β2-agonist prior to the study | 14 |
Mean FEV1, L (range) | 3.26 (2.11-4.69) |
Mean FEV1, % predicted (range) | 94.6 (63-126) |
Geometric mean PC20-AMP, mg/ml (range) | 2.64 (0.08-125) |